Butalbital, Aspirin, And Caffeine
Product Images NDC 29033-215
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Butalbital, Aspirin, And Caffeine (NDC 29033-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nostrum Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel Ndc 29033-215-01 (Bac Cont Lbl 100)
This is a medication called Butalbital, Aspirin, and Caffeine Capsules, USP that contains 50 mg of Butalbital, USP, 325 mg of Aspirin, USP, and 40 mg of Caffeine, USP per capsule. The usual adult dosage is 1 or 2 capsules every four hours, and the total daily dose should not exceed 6 capsules. It should be stored at 20° to 25°C (68° to 77°F) and protected from moisture. Dispense in a tight container as defined in the USP with a child-resistant closure. Keep out of the reach of children. The medication is prescription-only and comes in a bottle containing 100 capsules manufactured by Nostrum Laboratories, Inc. located in Kansas City, MO.*
The Following Structural Formula For Butalbital (5-allyl-5-isobutylbarbituric Acid) Is A Short- To Intermediate-acting Barbiturate. (Butalbital Struc)
The Following Structural Formula For Caffeine (1,3,7-trimethylxanthine) Is A Central Nervous System Stimulant. (Caffeine Struc)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.